Vaxxinity | search
Click here to view Vaxxinity news from 60+ newspapers.
Bookmark or Share- News Releases | VaxxinityCAPE CANAVERAL, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX ), a U.S. company pioneering the development of a new class of medicines, today announced it will present clinical data from its UB-312 program in Parkinson’s disease and preclinical data from its anti-tau program. 30 Jan '24.
- Vaxxinity, Inc. (VAXX) - Yahoo FinanceFind the latest Vaxxinity, Inc. (VAXX) stock quote, history, news and other vital information to help you with your stock trading and investing.
- Our Mission - VaxxinityFor the first time in history, chronic diseases are killing us more than infectious diseases. One reason is that vaccines, the first biologic revolution, have been so successful and prolific. There are today 29 vaccine-preventable diseases and over 80% of the world is vaccinated.
- Home - VaxxinityOur mission is to democratize health by pioneering the third biologic revolution.
- A Potential Parkinson's Treatment Has Promising Results | TIMEThe Florida-based biotech company Vaxxinity developed a vaccine, or what it calls an active immune medicine, to train the immune system to attack only abnormal versions of the...
More
